Gadoquatrane
Records for this ingredient, by country (identity only).
ATC V08CA13 · 3 markets · 16 records
US 11 records · 1 shown of 1
- 257.9 mg per mL / per unit basis not statedinjectionAmbelvist
JP 4 records · 4 shown of 4
- 25.79 %/2 mLinjectionアムベルビスト静注2mL
- 25.79 %/5 mLinjectionアムベルビスト静注シリンジ10mL
- 25.79 %/7.5 mLinjectionアムベルビスト静注シリンジ10mL
- 25.79 %/10 mLinjectionアムベルビスト静注シリンジ10mL
CA 1 records · 1 shown of 1
- 257.9 mg per mL / per unit basis not statedliquidAmbelvist
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.